Sytech(600183) 21世纪经济报道·2025-05-11 14:37Core Insights - The overall performance of over 60 listed companies in Dongguan shows a stark contrast, with rapid growth in R&D investment despite varying financial results [1][2] - The leading companies in R&D spending are Shengyi Technology, Aohai Technology, and Shengyi Electronics, with investments of 1.156 billion, 352 million, and 283.6 million respectively [1][2] - The electronic information industry leads in R&D investment among Dongguan's listed companies, reflecting its technology-intensive nature [2][3] R&D Investment Overview - 27 listed companies in Dongguan reported R&D expenditures exceeding 100 million, with nine companies surpassing 200 million [6] - Shengyi Technology's R&D investment increased by 37.57% year-on-year, reaching 1.156 billion in 2024, compared to 840 million in 2023 [2][3] - Aohai Technology's R&D expenses reached 352 million, a 14.14% increase, accounting for 5.48% of its revenue [4][5] Industry Trends - The electronic industry is experiencing structural improvements due to the rise of AI and new technologies, with global semiconductor revenue growing by 18.1% [3] - The demand for AI servers and data center equipment is driving growth in the semiconductor sector, alongside a recovery in the consumer electronics market [3] - Shengyi Technology's R&D focuses on advanced technologies such as low-loss copper-clad laminates for next-generation servers and high-end AI servers [3][7] Company-Specific Developments - Aohai Technology has accumulated 730 global patents, with a focus on core technologies to meet diverse energy application needs [5] - Yutong Optical's R&D investment grew by 41.56% to 172.8 million, with a significant increase in R&D personnel [5][6] - Sijuan New Materials reported the highest R&D growth rate at 56.42%, with a focus on heat dissipation solutions [6][7] Declining R&D Investments - St. Quanwei experienced a significant drop in R&D investment, down 61.09% to 13.72 million, due to a reduction in personnel [8] - Hongyuan A reported a complete cessation of R&D investment, attributing it to market constraints affecting profitability [8]